Abstract
Purpose
Shortening of the QRS duration (QRSd) is often used to guide device optimization and reprogramming in patients with cardiac resynchronization therapy (CRT). Detecting the small changes expected during reprogramming requires that the QRSd can be measured with high precision, but this has never been studied in patients with CRT.
In this study, we wanted to assess the precision of automated QRSd measurement in patients treated with CRT using two commonly available electrocardiographs.
Methods
Patients treated with CRT were recruited during routine follow-up in our pacemaker clinic. In all participants, a number of immediate successive ECGs were recorded with the GE MAC 5500 (Mac55) and the GE MAC 1600 (Mac16). Data were analyzed with a linear mixed model.
Results
A total of 785 12-lead ECGs were recorded in 36 patients with an average of 11.2 and 10.6 ECGs per patient with the Mac55 and Mac16, respectively. The Mac55 measured the QRSd longer by 10.3 milliseconds (ms) (95% CI 7.1–13.5 ms, p < 0.001) and with significantly smaller standard deviation for repeated measurements (6.3 vs. 10.4 ms, p < 0.001). Limits of agreement were ± 17.5 and ± 28.8 ms for the Mac55 and Mac16, respectively.
Conclusions
Automated measurement of QRSd in patients with CRT shows low precision with limits of agreement of ± 17.5 and ± 28.8 ms for repeated measurements in two commercially available electrocardiographs. Device programming solely by QRSd changes should be done with caution, and clinical effects should be demonstrated in future trials. Device programming based on QRSd changes should be done with caution until the ability of this measure to predict clinical outcome can be demonstrated in prospective study.
Similar content being viewed by others
References
Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European heart rhythm association (EHRA). Eur Heart J. 2013;34:2281–329.
Korantzopoulos P, Zhang Z, Li G, Fragakis N, Liu T. Meta-analysis of the usefulness of change in QRS width to predict response to cardiac resynchronization therapy. Am J Cardiol. 2016;118:1368–73.
Gold MR, Thebault C, Linde C, Abraham WT, Gerritse B, Ghio S, et al. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) study. Circulation. 2012;126:822–9.
Forleo GB, Santini L, Giammaria M, Potenza D, Curnis A, Calabrese V, et al. Multipoint pacing via a quadripolar left-ventricular lead: preliminary results from the Italian registry on multipoint left-ventricular pacing in cardiac resynchronization therapy (IRON-MPP). Europace. 2017;19:1170–7.
Tamborero D, Mont L, Sitges M, Silva E, Berruezo A, Vidal B, et al. Optimization of the interventricular delay in cardiac resynchronization therapy using the QRS width. Am J Cardiol. 2009;104:1407–12.
Sweeney MO, Hellkamp AS, Van Bommel RJ, Schalij MJ, Borleffs CJ, Bax JJ. QRS fusion complex analysis using wave interference to predict reverse remodeling during cardiac resynchronization therapy. Heart Rhythm. 2014;11:806–13.
De Guillebon M, Thambo JB, Ploux S, Deplagne A, Sacher F, Jais P, et al. Reliability and reproducibility of QRS duration in the selection of candidates for cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2010;21:890–2.
De Pooter J, El Haddad M, Timmers L, Van Heuverswyn F, Jordaens L, Duytschaever M, et al. Different methods to measure QRS duration in CRT patients: impact on the predictive value of QRS duration parameters. Ann Noninvasive Electrocardiol. 2016;21:305–15.
De Pooter J, El Haddad M, Stroobandt R, De Buyzere M, Timmermans F. Accuracy of computer-calculated and manual QRS duration assessments: clinical implications to select candidates for cardiac resynchronization therapy. Int J Cardiol. 2017;236:276–82.
Vancura V, Wichterle D, Ulc I, Smid J, Brabec M, Zarybnicka M, et al. The variability of automated QRS duration measurement. Europace. 2017;19:636–43.
Huang T, James CA, Tichnell C, Murray B, Xue J, Calkins H, et al. Statistical evaluation of reproducibility of automated ECG measurements: an example from arrhythmogenic right ventricular dysplasia/cardiomyopathy clinic. Biomed Signal Process Control. 2014;13:23–30.
Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–10.
Guo T, Li R, Zhang L, Luo Z, Zhao L, Yang J, et al. Biventricular pacing with ventricular fusion by intrinsic activation in cardiac resynchronization therapy. Int Heart J. 2015;56:293–7.
Coppola G, Ciaramitaro G, Stabile G, DO A, Palmisano P, Carita P, et al. Magnitude of QRS duration reduction after biventricular pacing identifies responders to cardiac resynchronization therapy. Int J Cardiol. 2016;221:450–5.
Tafreshi R, Jaleel A, Lim J, Tafreshi L. Automated analysis of ECG waveforms with atypical QRS complex morphologies. Biomed Signal Process Control. 2014;10:41–9.
Tomlinson DR, Bashir Y, Betts TR, Rajappan K. Accuracy of manual QRS duration assessment: its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy. Europace. 2009;11:638–42.
Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation. 2008;117:2608–16.
Gras D, Gupta MS, Boulogne E, Guzzo L, Abraham WT. Optimization of AV and VV delays in the real-world CRT patient population: an international survey on current clinical practice. Pacing Clin Electrophysiol. 2009;32(Suppl 1):S236–9.
Brugada J, Delnoy PP, Brachmann J, Reynolds D, Padeletti L, Noelker G, et al. Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. Eur Heart J. 2017;38:730–8.
Singh JP, Abraham WT, Chung ES, Rogers T, Sambelashvili A, Coles JA Jr, et al. Clinical response with adaptive CRT algorithm compared with CRT with echocardiography-optimized atrioventricular delay: a retrospective analysis of multicentre trials. Europace. 2013;15:1622–8.
Funding
This work was supported by “Innovationsfonden” (grant no. 72-2014-1).
Author information
Authors and Affiliations
Author notes
Helen H. Petersen is deceased. This paper is dedicated to his memory.
- Helen H. Petersen
Corresponding author
Ethics declarations
This study was approved by the regional ethics committee and conforms to the Declaration of Helsinki. All authors had full access to data and have read and agreed to the final manuscript.
Informed consent
All participants provided written, informed consent. The study is approved by the Danish Data protection authorities.
Conflict of interest
C. Lund-Andersen has received congress fees from Medtronic and St. Jude Medical. Jesper H. Svendsen has received grants from Medtronic, Biotronik, Gilead, and St. Jude Medical and speaker fees from Medtronic, Biotronik, Astra Zeneca, Boehringer Ingelheim, and Bayer. C. Jønz has received consultant fees from Biotronik.
Rights and permissions
About this article
Cite this article
Lund-Andersen, C., Petersen, H.H., Jøns, C. et al. Precision of automated QRS duration measurement in patients treated with cardiac resynchronization therapy. J Interv Card Electrophysiol 52, 103–110 (2018). https://doi.org/10.1007/s10840-018-0334-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-018-0334-2